PolyPid Regains European Rights for D-PLEX100
PolyPid Ltd. announced it has regained the European commercialization rights for its D-PLEX100 product from ADVANZ PHARM. This move expands the company's global commercialization opportunities.
PolyPid Ltd. announced it has regained the European commercialization rights for its D-PLEX100 product from ADVANZ PHARM. This move expands the company's global commercialization opportunities.